Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients – results from real-life prospective study
Horňák, Tomáš, Semerád, Lukáš, Žáčková, Daniela, Weinbergerová, Barbora, Šustková, Zuzana, Procházková, Jiřina, Bělohlávková, Petra, Stejskal, Lukáš, Rohoň, Peter, Faber, Edgar, Žák, Pavel, Mayer, JiřJournal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2019.1672054
Date:
October, 2019
Fichier:
PDF, 630 KB
2019
File converter
Plus de résultats de recherche
More benefits 
